Supernus Pharmaceuticals (SUPN) P/E (2012 - 2026)
Supernus Pharmaceuticals (SUPN) P/E from Jul 2, 2012 to Jun 2, 2026. The TTM Supernus Pharmaceuticals (SUPN) P/E is -88.14. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Supernus Pharmaceuticals (SUPN)
| Year | P/E | Change |
|---|---|---|
| 2026 | -88.14 | +19.15% |
| 2025 | -73.98 | -373.39% |
| 2024 | 27.06 | -55.85% |
| 2023 | 61.28 | +21.56% |
| 2022 | 50.42 | +74.64% |
| 2021 | 28.87 | +176.51% |
| 2020 | 10.44 | -5.15% |
| 2019 | 11.01 | -29.41% |
| 2018 | 15.59 | -17.55% |
| 2017 | 18.91 | +22.71% |
| 2016 | 15.41 | -8.65% |
| 2015 | 16.87 | +287.32% |
| 2014 | 4.36 | -141.04% |
| 2013 | -10.61 | +107.46% |
| 2012 | -5.12 | N/A |
Comparison Supernus Pharmaceuticals (SUPN) P/E with competitors
Supernus Pharmaceuticals (SUPN) P/E is -88.14.